Compounds > torcetrapib
Page last updated: 2024-09-04

torcetrapib and Arteriosclerosis

torcetrapib has been researched along with Arteriosclerosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brewer, HB1
Maeda, K; Okamoto, H; Shinkai, H1
Boekholdt, SM; Hovingh, GK; Kastelein, JJ; Klerkx, AH; Kuivenhoven, JA; van der Steeg, WA1
Stein, O; Stein, Y1

Reviews

2 review(s) available for torcetrapib and Arteriosclerosis

ArticleYear
Role of CETP inhibitors in the treatment of dyslipidemia.
    Current opinion in lipidology, 2004, Volume: 15, Issue:6

    Topics: Amides; Animals; Arteriosclerosis; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Esters; Glycoproteins; Humans; Hyperlipidemias; Hypolipidemic Agents; Quinolines; Sulfhydryl Compounds

2004
Lipid transfer proteins (LTP) and atherosclerosis.
    Atherosclerosis, 2005, Volume: 178, Issue:2

    Topics: Absorption; Animals; Arteriosclerosis; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Clinical Trials as Topic; Disease Models, Animal; Enzyme Inhibitors; Epidemiologic Studies; Gene Transfer Techniques; Glycoproteins; Humans; Membrane Proteins; Mice; Oxidative Stress; Phosphatidylcholine-Sterol O-Acyltransferase; Phospholipid Transfer Proteins; Quinolines; Rabbits; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2

2005

Other Studies

2 other study(ies) available for torcetrapib and Arteriosclerosis

ArticleYear
High-density lipoproteins: a new potential therapeutic target for the prevention of cardiovascular disease.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:3

    Topics: Animals; Arteriosclerosis; Biological Transport; Cardiovascular Diseases; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Enzyme Inhibitors; Glycoproteins; Humans; Lipoproteins, HDL; Liver; Macrophages; Mice; Mice, Transgenic; Oxidation-Reduction; Quinolines; Rabbits; Risk Factors

2004
S-(2-(acylamino)phenyl) 2,2-dimethylpropanethioates as CETP inhibitors.
    Bioorganic & medicinal chemistry letters, 2004, May-17, Volume: 14, Issue:10

    Topics: Amides; Arteriosclerosis; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Esters; Glycoproteins; Humans; Inhibitory Concentration 50; Protective Agents; Quinolines; Structure-Activity Relationship; Sulfhydryl Compounds

2004